Home > Insider Trading > Filing (0001493152-24-011034)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1862150	Cingulate Inc.	CING	Pharmaceutical Preparations (2834)	863825535

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1883523	L. Jennifer Callahan	1901 W. 47Th Place Kansas City KS 66205	Svp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-15	55	$27.10	2,333	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2022-03-15	1,500	$0.30	75	$120.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,030	2021-12-10	2026-12-10	No	4	P	Direct

Footnotes

The number of shares and price reflect the 1-for-20 reverse stock split of the Issuer's issued and outstanding shares of common stock, which became effective on November 30, 2023.
Total number of securities includes purchases reflected on Forms 4 filed subsequent to the purchases this Form 4 covers.
The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2999 to $0.3094 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth herein.